TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 17602297

Group type: EXPERIMENTAL
Intervention: Community demographics (poverty)
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Social capital
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Team member attitudes towards prevention
Number of subjects: 137

Group type: EXPERIMENTAL
Intervention: Team members' views of the acceptability of teen alcohol use
Number of subjects: 137
Study: 15629339

Group type: EXPERIMENTAL
Intervention: Superficial cervical block
Number of subjects: 125

Group type: COMPARATOR
Intervention: Combined cervical block
Number of subjects: 125

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 125
Study: 11929646

Group type: EXPERIMENTAL
Intervention: Expert contraceptive advice (participants, n = 771)
Number of subjects: 1637

Group type: COMPARATOR
Intervention: Standard advice routinely given in that setting (controls, n = 866)
Number of subjects: 1637
Study: 10022402

Group type: EXPERIMENTAL
Intervention: Calcium supplementation
Number of subjects: 390

Group type: COMPARATOR
Intervention: Nonlactating women
Number of subjects: 390
Study: 7756797

Group type: EXPERIMENTAL
Intervention: Maternal pethidine
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (no pethidine)
Number of subjects: 44
Study: 2274758

Group type: EXPERIMENTAL
Intervention: Right visual half-field group (isolation and repression)
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Left visual half-field measure (regressive strategies)
Number of subjects: 84

Group type: COMPARATOR
Intervention: High creative subjects
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: High creative persons
Number of subjects: 84
Study: 7308331

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg in ordinary tablets
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Metoprolol 200 mg in slow-release tablets
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Terbutaline (beta 2-receptor stimulating agent)
Number of subjects: 8
Study: 31402235

Group type: EXPERIMENTAL
Intervention: Narrow regimen
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Expanded gram-negative regimen
Number of subjects: 252

Group type: EXPERIMENTAL
Intervention: Fluoroquinolone-based regimen
Number of subjects: 252
Study: 30803084

Group type: EXPERIMENTAL
Intervention: CaringGuidance plus usual care
Number of subjects: 100

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 100
Study: 27930941

Group type: EXPERIMENTAL
Intervention: LNG‐IUS 12
Number of subjects: 2885
Study: 26369489

Group type: EXPERIMENTAL
Intervention: salivary substitute as an adjunct to scaling and root planing (SRP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: scaling and root planing (SRP)
Number of subjects: 40
Study: 24372304

Group type: EXPERIMENTAL
Intervention: 3K3A-APC at 6, 30, 90, 180, 360, 540 or 720 µg/kg
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: 3K3A-APC at 90, 180, 360, or 540 µg/kg
Number of subjects: 64

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study: 21392372

Group type: EXPERIMENTAL
Intervention: Standard treatment plus Manual Lymphatic Drainage
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard treatment (skin care, exercise, compression measures, bandages for one month, and compression garments)
Number of subjects: 58
Study: 19711495

Group type: EXPERIMENTAL
Intervention: Culturally tailored cervical cancer education program in three weekly sessions
Number of subjects: 398

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 398
Study: 18685533

Group type: EXPERIMENTAL
Intervention: Pedometer monitoring for 28 consecutive days
Number of subjects: 212

Group type: EXPERIMENTAL
Intervention: Pedometer monitoring for 1 week
Number of subjects: 212
Study: 16125536

Group type: EXPERIMENTAL
Intervention: Rosiglitazone 4 mg daily
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (no rosiglitazone)
Number of subjects: 40
Study: 12163785

Group type: EXPERIMENTAL
Intervention: Innovative pulse oximeter (IPO)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Conventional pulse oximeter (CPO)
Number of subjects: 86
Study: 10022641

Group type: EXPERIMENTAL
Intervention: Plantago ovata seeds (10 g b.i.d.)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Mesalamine (500 mg t.i.d.)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Plantago ovata seeds plus mesalamine (same doses)
Number of subjects: 105

Group type: EXPERIMENTAL
Intervention: Plantago ovata seeds
Number of subjects: 105

Group type: COMPARATOR
Intervention: Mesalamine
Number of subjects: 105
Study: 7496561

Group type: EXPERIMENTAL
Intervention: Atropine 1 mg (antimuscarinic)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Nicergoline 2.5 mg (alpha blocker)
Number of subjects: 7

Group type: EXPERIMENTAL
Intervention: Esmolol 40 mg (beta 1 blocker)
Number of subjects: 7

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 7
Study: 2351321

Group type: EXPERIMENTAL
Intervention: Pelvic irradiation + cyclophosphamide
Number of subjects: 118

Group type: COMPARATOR
Intervention: Abdominal irradiation
Number of subjects: 118
Study: 98127

Group type: EXPERIMENTAL
Intervention: Penfluridol, 20 to 160 mg orally once each week
Number of subjects: 60

Group type: COMPARATOR
Intervention: Fluphenazine decanoate, 0.5 to 4 ml every two weeks
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (retrospective comparison)
Number of subjects: 60
Study: 30311042

Group type: EXPERIMENTAL
Intervention: FOLFIRI (in L2 for ECX arm)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: ECX (in L2 for FOLFIRI arm)
Number of subjects: 416

Group type: COMPARATOR
Intervention: L2 treatment (compared to L1 only)
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Age < 60 years at diagnosis
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: ECOG score 2 before L2
Number of subjects: 416

Group type: EXPERIMENTAL
Intervention: Age ≥ 60 years at diagnosis and ECOG score 0/1 before L2
Number of subjects: 416
Study: 28361371

Group type: EXPERIMENTAL
Intervention: Beta-blocker up-titration over 12 weeks
Number of subjects: 530
Study: 25719757

Group type: EXPERIMENTAL
Intervention: Dexamethasone
Number of subjects: 42

Group type: COMPARATOR
Intervention: Normal saline solution
Number of subjects: 42
Study: 23752260

Group type: EXPERIMENTAL
Intervention: CareCall (telehealth intervention)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 142
Study: 21488802

Group type: EXPERIMENTAL
Intervention: Acarbose 100 mg three times daily
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 66
Study: 17989314

Group type: EXPERIMENTAL
Intervention: Stem-cell transplantation (SCT) from an alternative donor
Number of subjects: 205

Group type: COMPARATOR
Intervention: Immunosuppressive therapy (IST) - second course
Number of subjects: 205
Study: 16549747

Group type: EXPERIMENTAL
Intervention: Microdebrider intracapsular tonsillectomy (MT)
Number of subjects: 74

Group type: COMPARATOR
Intervention: Monopolar electrocautery tonsillectomy (ET)
Number of subjects: 74
Study: 12882864

Group type: EXPERIMENTAL
Intervention: AC2993 (0.08 micro g/kg)
Number of subjects: 109

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 109
Study: 11077932

Group type: EXPERIMENTAL
Intervention: Zinc sulphate (177 mg/kg/day in three divided doses equivalent to 40 mg elemental zinc)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 80
Study: 9206049

Group type: EXPERIMENTAL
Intervention: Postoperative chemotherapy
Number of subjects: 404

Group type: EXPERIMENTAL
Intervention: Intraoperative chemotherapy
Number of subjects: 404

Group type: COMPARATOR
Intervention: Surgery alone (Control)
Number of subjects: 404
Study: 1341621

Group type: EXPERIMENTAL
Intervention: Non-randomized comparison groups
Number of subjects: 0

Group type: COMPARATOR
Intervention: Current device (implied control)
Number of subjects: 0
Study: 6209506

Group type: EXPERIMENTAL
Intervention: Tyramine, 15.0 micrograms/kg/min for 30 min
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Cold exposure at 4 degrees C for 30 min
Number of subjects: 0

Group type: COMPARATOR
Intervention: Propranolol, 160 mg (single oral dose)
Number of subjects: 0
Study: 30660582

Group type: COMPARATOR
Intervention: Compression stockings (compared with placebo)
Number of subjects: 6162

Group type: COMPARATOR
Intervention: Long-term compression (compared with short-term compression)
Number of subjects: 6162

Group type: EXPERIMENTAL
Intervention: Extended tinzaparin (LMWH)
Number of subjects: 6162

Group type: COMPARATOR
Intervention: Procedural thrombolysis
Number of subjects: 6162

Group type: COMPARATOR
Intervention: Streptokinase (medical thrombolysis)
Number of subjects: 6162
Study: 30185196

Group type: EXPERIMENTAL
Intervention: Lantern-shaped screw loaded with autogenous bone
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control group (core decompression and autogenous bone graft)
Number of subjects: 32
Study: 27079676

Group type: EXPERIMENTAL
Intervention: Palliative care consultation (PCC)
Number of subjects: 85

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 85
Study: 25318980

Group type: EXPERIMENTAL
Intervention: Nutrition education package (comprising education and counselling of mothers, training community-based nutrition counsellors, sensitisation meetings with health staff and family members, supervision of community-based nutrition counsellors)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Routine health education offered monthly by health staff at health facilities
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nutrition education package
Number of subjects: 0
Study: 22071199

Group type: EXPERIMENTAL
Intervention: Low calorie diets and a program of exercises
Number of subjects: 150

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 150
Study: 19730861

Group type: EXPERIMENTAL
Intervention: Vascularised bone graft from the dorsal and distal aspect of the radius (group I)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Conventional non‐vascularised bone graft from the distal radius (group II)
Number of subjects: 46
Study: 18563969

Group type: EXPERIMENTAL
Intervention: Most preferred music
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Least preferred music
Number of subjects: 0

Group type: COMPARATOR
Intervention: No music
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High intensity exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Moderate intensity exercise
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Low intensity exercise
Number of subjects: 0
Study: 16018851

Group type: EXPERIMENTAL
Intervention: Topiramate 96 mg/day
Number of subjects: 531

Group type: EXPERIMENTAL
Intervention: Topiramate 192 mg/day
Number of subjects: 531

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 531
Study: 15208937

Group type: EXPERIMENTAL
Intervention: Low Molecular Weight Chitosan (LMWCh)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: High Molecular Weight Chitosan (HMWCh)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Hexetidine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Triclosan
Number of subjects: 0
Study: 10335764

Group type: EXPERIMENTAL
Intervention: High-dose simvastatin (80 mg)
Number of subjects: 842

Group type: EXPERIMENTAL
Intervention: Low-dose simvastatin (40 mg)
Number of subjects: 842

Group type: COMPARATOR
Intervention: High-dose atorvastatin (40 mg)
Number of subjects: 842

Group type: COMPARATOR
Intervention: Low-dose atorvastatin (20 mg)
Number of subjects: 842
Study: 8935744

Group type: EXPERIMENTAL
Intervention: Thiamine hydrochloride (vitamin B1) 100 mg orally, daily for 90 days
Number of subjects: 556

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 556
Study: 1708499

Group type: EXPERIMENTAL
Intervention: buprenorphine
Number of subjects: 20

Group type: COMPARATOR
Intervention: morphine
Number of subjects: 20

Group type: COMPARATOR
Intervention: meperidine
Number of subjects: 20
Study: 6811511

Group type: EXPERIMENTAL
Intervention: High carbohydrate intake with potassium supplementation
Number of subjects: 4

Group type: COMPARATOR
Intervention: High carbohydrate intake without potassium supplementation
Number of subjects: 4
Study: 31401973

Group type: EXPERIMENTAL
Intervention: 7.5 mg/kg rabbit ATG
Number of subjects: 408

Group type: EXPERIMENTAL
Intervention: 10.0 mg/kg rabbit ATG
Number of subjects: 408
Study: 29958863

Group type: EXPERIMENTAL
Intervention: Enhanced image technique
Number of subjects: 59

Group type: COMPARATOR
Intervention: Original image technique
Number of subjects: 59
Study: 27895542

Group type: EXPERIMENTAL
Intervention: Tart cherry juice (CJ)
Number of subjects: 9

Group type: COMPARATOR
Intervention: Placebo equivalent (PLA)
Number of subjects: 9
Study: 24801768

Group type: EXPERIMENTAL
Intervention: Olanzapine/fluoxetine combination (OFC)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Fluoxetine
Number of subjects: 444
Study: 22578975

Group type: EXPERIMENTAL
Intervention: Easy separation from CPB (no support or one vasoactive agent/inotrope)
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: Difficult separation from CPB (two drug types used)
Number of subjects: 2331

Group type: EXPERIMENTAL
Intervention: Complex separation from CPB (first weaning process failed or mechanical devices required)
Number of subjects: 2331
Study: 19507027

Group type: EXPERIMENTAL
Intervention: Enteric-coated, delayed-release peppermint oil (Colpermin)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 18029880

Group type: EXPERIMENTAL
Intervention: New splenic grading system
Number of subjects: 400

Group type: COMPARATOR
Intervention: AAST injury scale
Number of subjects: 400
Study: 16178825

Group type: EXPERIMENTAL
Intervention: Individualised training for GP trainers
Number of subjects: 47

Group type: COMPARATOR
Intervention: No specific programme for control group
Number of subjects: 47
Study: 12037657

Group type: EXPERIMENTAL
Intervention: Non-diet wellness program
Number of subjects: 78

Group type: COMPARATOR
Intervention: Traditional diet program
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 78

Group type: COMPARATOR
Intervention: Diet group
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Non-diet group
Number of subjects: 78
Study: 10459961

Group type: EXPERIMENTAL
Intervention: Intra-arterial 131I-lipiodol (1850 MBq)
Number of subjects: 43

Group type: COMPARATOR
Intervention: No adjuvant treatment (control)
Number of subjects: 43
Study: 7792281

Group type: EXPERIMENTAL
Intervention: Exercise confined to early pregnancy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Exercise throughout pregnancy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Matched controls (no exercise)
Number of subjects: 0
Study: 2193303

Group type: EXPERIMENTAL
Intervention: Corticosteroids (betamethasone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 760589

Group type: EXPERIMENTAL
Intervention: Oral oxazepam
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study: 30670227

Group type: EXPERIMENTAL
Intervention: 3RP‐NF (Relaxation Response Resiliency Program for NF)
Number of subjects: 31
Study: 28659136

Group type: EXPERIMENTAL
Intervention: Overweight group (BMI > normal)
Number of subjects: 95126

Group type: EXPERIMENTAL
Intervention: Obese group (BMI > overweight)
Number of subjects: 95126

Group type: EXPERIMENTAL
Intervention: <1-15 units/week alcohol consumption
Number of subjects: 95126

Group type: EXPERIMENTAL
Intervention: 16-20 units/week alcohol consumption
Number of subjects: 95126

Group type: EXPERIMENTAL
Intervention: >=21 units/week alcohol consumption
Number of subjects: 95126

Group type: EXPERIMENTAL
Intervention: Obese women consuming >=21 units/week
Number of subjects: 95126

Group type: EXPERIMENTAL
Intervention: Obese women drinking <1-15 units/week
Number of subjects: 95126

Group type: EXPERIMENTAL
Intervention: Normal BMI consuming >=21 units/week
Number of subjects: 95126
Study: 25772548

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg as add-on to sulphonylurea
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg as add-on to sulphonylurea
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg as add-on to other therapies
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Empagliflozin 25 mg as add-on to other therapies
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Empagliflozin 10 mg and 25 mg
Number of subjects: 1000
Study: 23369827

Group type: EXPERIMENTAL
Intervention: Ferric citrate 1 g/d
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Ferric citrate 6 g/d
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Ferric citrate 8 g/d
Number of subjects: 151
Study: 21079990

Group type: EXPERIMENTAL
Intervention: Ice vest combined with hand/forearm immersion (VEST + W)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Hand/forearm immersion (W)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ice vest (VEST)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Control (CON)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: VEST + W and W
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Cooling conditions (VEST + W and W)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ice vests and hand/forearm immersion
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Ice vests combined with hand/forearm immersion
Number of subjects: 8
Study: 20122033

Group type: EXPERIMENTAL
Intervention: Coping and communication support (CCS) intervention
Number of subjects: 210
Study: 17491177

Group type: EXPERIMENTAL
Intervention: Cell Phone Intervention (CPI)
Number of subjects: 95

Group type: COMPARATOR
Intervention: Recommended Standard of Care (RSOC)
Number of subjects: 95
Study: 15677430

Group type: EXPERIMENTAL
Intervention: Combined T4 plus T3
Number of subjects: 40

Group type: COMPARATOR
Intervention: T4 alone
Number of subjects: 40
Study: 11696916

Group type: EXPERIMENTAL
Intervention: 830 nm laser irradiation (4.8 J per session)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Sham laser treatment (control group)
Number of subjects: 12
Study: 11967825

Group type: EXPERIMENTAL
Intervention: Captopril
Number of subjects: 86

Group type: EXPERIMENTAL
Intervention: Enalapril
Number of subjects: 86

Group type: COMPARATOR
Intervention: Untreated
Number of subjects: 86
Study: 8633373

Group type: EXPERIMENTAL
Intervention: Pravastatin
Number of subjects: 48

Group type: COMPARATOR
Intervention: No pravastatin (Control)
Number of subjects: 48
Study: 1730427

Group type: EXPERIMENTAL
Intervention: Intraperitoneal radioactive phosphorus
Number of subjects: 93

Group type: COMPARATOR
Intervention: Oral melphalan
Number of subjects: 93

Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 93
Study: 6236576

Group type: EXPERIMENTAL
Intervention: ipratropium bromide 40 micrograms
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: ipratropium bromide 200 micrograms or more
Number of subjects: 11

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 11
Study: 30595035

Group type: EXPERIMENTAL
Intervention: Caponisation
Number of subjects: 200

Group type: COMPARATOR
Intervention: Cockerels (control)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Older capons (24 and 28 weeks)
Number of subjects: 200
Study: 29748907

Group type: EXPERIMENTAL
Intervention: Alfacalcidol (VDRA) 0.25-0.5 µg once a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Alfacalcidol (VDRA) 0.25-0.5 µg once a day + Lanthanum carbonate (LC) 250 mg once a day
Number of subjects: 0
Study: 26459503

Group type: EXPERIMENTAL
Intervention: Educational nursing home visits
Number of subjects: 123

Group type: COMPARATOR
Intervention: Care as usual (Control)
Number of subjects: 123
Study: 24670828

Group type: EXPERIMENTAL
Intervention: Drug Eluting Balloon (DEB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Conventional Angioplasty Balloon (PTA)
Number of subjects: 50
Study: 22452942

Group type: EXPERIMENTAL
Intervention: Granisetron transdermal system (GTDS)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Intravenous granisetron
Number of subjects: 240

Group type: COMPARATOR
Intervention: Oral moxifloxacin (active control)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 240
Study: 21156079

Group type: EXPERIMENTAL
Intervention: Heat-sensitive moxibustion
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fluticasone/salmeterol (seretide)
Number of subjects: 0
Study: 16949264

Group type: EXPERIMENTAL
Intervention: Formoterol as-needed (3.95% asthma exacerbations; 7 of 177 patients)
Number of subjects: 359

Group type: COMPARATOR
Intervention: Formoterol twice daily (3.45% asthma exacerbations; 6 of 174 patients)
Number of subjects: 359

Group type: EXPERIMENTAL
Intervention: Formoterol as-needed
Number of subjects: 359

Group type: COMPARATOR
Intervention: Formoterol twice daily supplemented by salbutamol
Number of subjects: 359
Study: 16318440

Group type: EXPERIMENTAL
Intervention: Docetaxel
Number of subjects: 1491

Group type: COMPARATOR
Intervention: 5-Fluorouracil
Number of subjects: 1491

Group type: COMPARATOR
Intervention: Paclitaxel
Number of subjects: 1491
Study: 12127382

Group type: EXPERIMENTAL
Intervention: Exercise only
Number of subjects: 1140

Group type: EXPERIMENTAL
Intervention: Education only
Number of subjects: 1140

Group type: EXPERIMENTAL
Intervention: Exercise and education combined
Number of subjects: 1140

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 1140
Study: 9667590

Group type: COMPARATOR
Intervention: Interferon-beta1b (IFN-beta1b) alone
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Interferon-beta1b (IFN-beta1b) in combination with pentoxifylline (PTX)
Number of subjects: 0
Study: 8537138

Group type: EXPERIMENTAL
Intervention: Cefixime 8 mg/kg body weight once daily for 5 days
Number of subjects: 151

Group type: COMPARATOR
Intervention: Penicillin V 20,000 I.U./kg body weight t.i.d. for 10 days
Number of subjects: 151
Study: 1973545

Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 0

Group type: COMPARATOR
Intervention: Neuroleptics
Number of subjects: 0
Study: 30508156

Group type: EXPERIMENTAL
Intervention: Regorafenib followed by cetuximab (R-C arm)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Cetuximab followed by regorafenib (C-R arm)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Regorafenib in R-C versus cetuximab in C-R
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Cetuximab in R-C versus regorafenib in C-R
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Quality of life scores during the entire treatment period
Number of subjects: 101